Ensign Peak Advisors, Inc Deciphera Pharmaceuticals, Inc. Transaction History

Ensign Peak Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$12.38 - $20.23 $213,431 - $348,765	-17,240 Reduced 43.26%	22,610 $418,000
Q1 2022 May 16, 2022	BUY	$6.87 - $11.11 $11,472 - $18,553	1,670 Added 4.37%	39,850 $369,000
Q4 2021 Feb 11, 2022	BUY	$7.7 - $37.13 $293,986 - $1.42 Million	38,180 New	38,180 $373,000
Q3 2020 Nov 12, 2020	SELL	$43.8 - $58.16 $73,058 - $97,010	-1,668 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$33.63 - $69.4 $56,094 - $115,759	1,668 New	1,668 $69,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.